LIVN
LivaNova PLC · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +6.7% ·
share flow -3.4% ·
net new positions +6.2%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 15.55K | $761,985 | n/a | n/a |
| Q2 2026 | 98 | -4 | 44.19M | $3.62B | +8 | −13 |
| Q1 2026 | 106 | +4 | 47.23M | $2.90B | +11 | −8 |
| Q4 2025 | 101 | +1 | 45.33M | $2.77B | +2 | n/a |
| Q3 2025 | 19 | -1 | 27.90M | $1.46B | n/a | −2 |
| Q2 2025 | 18 | -1 | 26.29M | $1.18B | n/a | −1 |
| Q1 2025 | 16 | +1 | 14.79M | $580.16M | +1 | n/a |
| Q4 2024 | 15 | 0 | 15.31M | $708.67M | +1 | −1 |
| Q3 2024 | 14 | 0 | 15.20M | $798.66M | +1 | −1 |
| Q2 2024 | 14 | n/a | 15.53M | $851.55M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 4.61M | -3.1% | $181.02M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 2.10M | -0.1% | $82.45M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 2.07M | -32.3% | $81.11M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 1.57M | +111.7% | $60.81M | 0.1% | ▲ Add | 4 | SEC ↗ ×5 |
| 5 | Geode Capital Management ✦ (passive) | 1.41M | +5.5% | $55.44M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Marshall Wace ✦ | 1.11M | +52.7% | $43.52M | 0.1% | ▲ Add | 4 | SEC ↗ ×3 |
| 7 | D. E. Shaw & Co. ✦ | 597.32K | +18.4% | $23.46M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 472.84K | +146.1% | $18.57M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Two Sigma Investments ✦ | 356.83K | -18.8% | $14.02M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 10 | Citadel Advisors ✦ | 153.21K | -6.6% | $6.02M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 146.66K | -85.8% | $5.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 63.84K | -24.7% | $2.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 51.69K | -54.1% | $2.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 41.34K | +11.2% | $1.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 27.82K | +2.2% | $1.09M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 18.22K | New | $715,799 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $715,799 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 289 holders, 58.28M shares, $3.62B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 3.50K sh · $273,032
Director · 2.30K sh · $187,270
Director · 1.65K sh · $131,538
Officer · 2.67K sh · $207,942
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology